Analyst Ratings for Beam Therapeutics Inc (BEAM) [Neutrals]
BEAM Rating Summary
BEAM Price Target Summary
- Highest: $78.00 (Guggenheim)
- Lowest: $30.00 (Jefferies)
- Average: $50.33
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$50.33 (+47.7%)
* Over Last 12-Mos
Rating Score: 4.3 / 10 Percentile Rank: 43%
Rating Score: 4.3 / 10 Percentile Rank: 43%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
12/15/2023 | BofA Securities | Greg Harrison | Downgrade | Neutral (Buy) |
35.00 (45.00) |
29.79 (34.07) |
14.37% | Details |
12/8/2023 | Jefferies | Michael Yee | Downgrade | Hold (Buy) |
30.00 (75.00) |
28.67 (34.07) |
18.84% | Details |